PT Medikaloka Hermina Tbk (IDX:HEAL)
Indonesia · Delayed Price · Currency is IDR 860.00
+10.00 (1.18%)
Jun 11, 2026, 4:13 PM WIB
PT Medikaloka Hermina Tbk Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, PT Medikaloka Hermina Tbk stock has a consensus rating of "Buy" and an average price target of Rp 1,552. The average 1-year stock price forecast is 80.50% higher than the current stock price, while the lowest is Rp 1,100 (+27.91%) and the highest is Rp 1,800 (+109.30%).
Price Target: Rp 1,552 (+80.50%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PT Medikaloka Hermina Tbk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 8 | 8 | 5 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 1 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Financial Forecast
Revenue This Year
7.78T
from 7.13T
Increased by 9.03%
Revenue Next Year
8.61T
from 7.78T
Increased by 10.72%
EPS This Year
33.74
from 28.40
Increased by 18.81%
EPS Next Year
41.45
from 33.74
Increased by 22.85%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is IDR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0T | ||
| Avg | 7.8T | ||
| Low | 7.5T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.5% | ||
| Avg | 9.0% | ||
| Low | 5.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 38.25 | ||
| Avg | 33.74 | ||
| Low | 30.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.7% | ||
| Avg | 18.8% | ||
| Low | 7.8% |